Generic and Biosimilar Medications

Foundation investor event: 2023 company profiles from Generic and Biosimilar Medicines Programme report

What Is a Biosimilar? - ENTtoday

Will Biosimilar Medications Reduce the Cost of Biologic Drugs? - Scientific American Blog Network

Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys

Biosimilar Medicines Equal More Accessible Care for Patients — Biosimilars Council

Biosimilars are here to help, really - Prime Therapeutics LLC

U.S. Consumers Overpay for Generic Drugs – USC Schaeffer

Biosimilars: Generic Biologics or Something Much More Complex? - Practical Dermatology

What Are Biosimilars? 8 Important Questions and Answers

Biosimilars and Cost Saving: Will Interchangeable Biosimilars Do to Biologics What Generic Drugs Did to Brand Name Medications?

Biosimilars: Not Simply Generics

What Are Biosimilars?

Pharmacy Pipeline Update - Healthgram

Biosimilars 101: considerations for U.S. oncologists in clinical practice - Camacho - 2014 - Cancer Medicine - Wiley Online Library

IGBA Whitepaper on vison for generic and biosimilar medicines industry